Photodynamic therapy (PDT) is dependent on the uptake of a photosensit
izing dye, often a porphyrin-related macrocycle, by the tumor or other
abnormal tissue that is to be treated, the subsequent irradiation of
the tumor with visible light of an appropriate wavelength matched to t
he absorption spectrum of the dye, and molecular oxygen to generate re
active oxygen intermediates. The initial oxidative reactions lead to d
amage to organelles in which the dye is bound, culminating in cell dea
th and destruction of the tumor or abnormal tissue. Apoptosis is a com
mon mechanism of cell death after PDT both in vitro and in vivo. PDT a
lso triggers the activation of several signal transduction pathways in
the treated cells; some of these are stress responses aimed at cell p
rotection, while others are likely to contribute to the cell death pro
cess. The photosensitizers of greatest interest in PDT bind to various
cytoplasmic membranes but are not found in the nucleus and do not bin
d to DNA. Nevertheless, some DNA damage is produced that can lead to m
utagenesis, the extent of which is dependent on the photosensitizer, t
he cellular repair properties and the target gene. Thus, in spite of g
enerating some responses common to ionizing radiation and other oxidat
ive stresses, PDT is unique in the subcellular localization of damage,
the combination of signaling pathways that are activated, and rapid k
inetics of the induction of cell death processes. (C) 1998 by Radiatio
n Research Society.